News

Stay Up to Date 
with the Latest
News.

The science
moves fast
and so do
the stories.

GliaX technology platform extension

Brain organoids to model epilepsy in GLUT1-DS published in Frontiers in Neuroscience (2024)

Collaboration with UMC Utrecht

GLIODEM BRAINS project with UMC Utrecht

ADDF Financing

Alzheimer’s disease: The Alzheimer’s Drug Discovery Foundation (ADDF) invests $4.2M in GliaPharm to advance its lead program

Collaboration

UCB

New hire at GliaPharm SA

New CDO & CMO

Collaboration

Wyss center

Innosuisse support

GliaPharm receives support from Innosuisse for a project to develop specific cell therapy to treat neurological diseases in collaboration with Universities of Bern and Lausanne.

HEPIA collaboration

GliaPharm receives grant for collaboration with HEPIA to setup a new 3D culture method using brain organoids from mouse and human-derived cells.

European Congress of Neuropsychopharmacology

GliaPharm to present at the European Congress of Neuropsychopharmacology – Symposium on “Beyond the Neurocentric Paradigm: Targeting Astrocytes and Neuroglial Interactions in CNS Disorders”. September 13th 2020.

LifeSci Symposium

GliaPharm presented at the LifeSci Partners Summer Symposium on August 5th 2020